BIO-TECHNE (TECH) Receivables: 2010-2025
Historic Receivables for BIO-TECHNE (TECH) over the last 16 years, with Sep 2025 value amounting to $183.9 million.
- BIO-TECHNE's Receivables fell 17.79% to $183.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $845.9 million, marking a year-over-year decrease of 6.06%. This contributed to the annual value of $206.9 million for FY2025, which is 14.30% down from last year.
- Per BIO-TECHNE's latest filing, its Receivables stood at $183.9 million for Q3 2025, which was down 11.11% from $206.9 million recorded in Q2 2025.
- BIO-TECHNE's 5-year Receivables high stood at $241.4 million for Q2 2024, and its period low was $145.4 million during Q2 2021.
- In the last 3 years, BIO-TECHNE's Receivables had a median value of $217.9 million in 2024 and averaged $216.9 million.
- Its Receivables has fluctuated over the past 5 years, first soared by 34.34% in 2021, then fell by 17.79% in 2025.
- Over the past 5 years, BIO-TECHNE's Receivables (Quarterly) stood at $152.9 million in 2021, then grew by 20.84% to $184.8 million in 2022, then grew by 12.28% to $207.5 million in 2023, then rose by 5.06% to $217.9 million in 2024, then decreased by 17.79% to $183.9 million in 2025.
- Its Receivables stands at $183.9 million for Q3 2025, versus $206.9 million for Q2 2025 and $237.1 million for Q1 2025.